HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan Weiss Selected Research

Benzoyl Peroxide

3/2018Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.
6/2016Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
12/2015Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
7/2010Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen.
11/2008An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
11/2007Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
2/2003Overall results of the BEST study following treatment of patients with mild to moderate acne.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan Weiss Research Topics

Disease

16Acne Vulgaris
12/2021 - 02/2003
8Neoplasms (Cancer)
10/2021 - 06/2009
6Lung Neoplasms (Lung Cancer)
01/2021 - 04/2009
6Psoriasis (Pustulosis Palmaris et Plantaris)
07/2019 - 08/2005
3Erythema
11/2021 - 06/2007
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 01/2018
2Hyperpigmentation
11/2021 - 01/2005
2Melanoma (Melanoma, Malignant)
01/2020 - 06/2015
2Pruritus (Itching)
07/2019 - 06/2007
2Rosacea (Acne Rosacea)
07/2017 - 01/2014
2Wounds and Injuries (Trauma)
01/2017 - 03/2014
2Carcinogenesis
04/2014 - 09/2008
2Adenocarcinoma of Lung
04/2014 - 12/2010
2Actinic Keratosis
07/2004 - 08/2002
1Hodgkin Disease (Hodgkin's Disease)
10/2021
1Residual Neoplasm
10/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Disease Progression
01/2020
1Pain (Aches)
07/2019
1Carcinoma (Carcinomatosis)
10/2018
1Hemorrhage
01/2017
1Psoriatic Arthritis
07/2014
1Burns
03/2014
1Neuroblastoma
12/2011
1Genomic Instability
09/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2009
1Leukemia
06/2009
1Sarcoma (Soft Tissue Sarcoma)
06/2009
1Inflammation (Inflammations)
09/2008
1Lentigo (Lentiginosis)
01/2005

Drug/Important Bio-Agent (IBA)

7Benzoyl PeroxideFDA LinkGeneric
03/2018 - 02/2003
6RetinoidsIBA
12/2021 - 02/2005
5Adapalene (Differin)FDA LinkGeneric
12/2021 - 11/2007
4DNA (Deoxyribonucleic Acid)IBA
10/2021 - 04/2014
3Pharmaceutical PreparationsIBA
09/2017 - 06/2009
3Clindamycin (Cleocin)FDA LinkGeneric
07/2017 - 02/2003
3ErbB Receptors (EGF Receptor)IBA
12/2010 - 04/2009
3Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010 - 01/2005
2Cell-Free Nucleic AcidsIBA
10/2021 - 10/2018
2Circulating Tumor DNAIBA
01/2021 - 01/2020
2venetoclaxIBA
11/2019 - 01/2018
2Minocycline (Cyclops)FDA LinkGeneric
10/2019 - 01/2019
2secukinumabIBA
07/2019 - 12/2016
2Anti-Bacterial Agents (Antibiotics)IBA
03/2018 - 03/2015
2Brimonidine Tartrate (Alphagan)FDA LinkGeneric
01/2017 - 01/2014
2Immunoglobulin A (IgA)IBA
06/2016 - 12/2015
2Anaplastic Lymphoma KinaseIBA
12/2011 - 12/2010
2Phosphotransferases (Kinase)IBA
10/2009 - 06/2009
2Fluorouracil (Carac)FDA LinkGeneric
07/2004 - 08/2002
1Melanins (Melanin)IBA
11/2021
1Lenalidomide (CC 5013)FDA Link
01/2021
1A 17 (A-17)IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1trifaroteneIBA
06/2019
1halobetasol (ulobetasol)FDA LinkGeneric
08/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2018
1tazarotene (Tazorac)FDA Link
08/2018
1Doxycycline (Periostat)FDA LinkGeneric
03/2018
1Isotretinoin (Accutane)FDA LinkGeneric
03/2018
1Interleukin-17 (Interleukin 17)IBA
12/2016
1Monoclonal AntibodiesIBA
12/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2015
1Proteinase-Activated ReceptorsIBA
03/2015
1ChemokinesIBA
03/2015
1CytokinesIBA
03/2015
1Adalimumab (Humira)FDA Link
07/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
07/2014
1ParaffinIBA
04/2014
1Formaldehyde (Formol)FDA Link
04/2014
1CatecholaminesIBA
03/2014
1NVP-TAE684IBA
12/2011
1CrizotinibIBA
12/2011
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
12/2010
1PD 173074IBA
12/2010
1PI103IBA
02/2010
1AfatinibIBA
02/2010
1TOR Serine-Threonine KinasesIBA
02/2010
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2010
1Oncogene Proteins (Oncogene Protein)IBA
10/2009
1tyrosine receptor (receptor, tyrosine)IBA
10/2009
1src-Family KinasesIBA
06/2009
1Dasatinib (BMS 354825)FDA Link
06/2009
1EphrinsIBA
06/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2009
1clindamycin phosphate (Clindets)FDA LinkGeneric
11/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2008
1Ointments (Pastes)IBA
04/2007
1Calcitriol (Calcijex)FDA LinkGeneric
04/2007
1EmollientsIBA
08/2005
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
08/2005

Therapy/Procedure

13Therapeutics
12/2021 - 02/2003
2Aftercare (After-Treatment)
10/2021 - 07/2004
2Microspheres (Microsphere)
07/2010 - 06/2007
1Immunotherapy
01/2020
1Dermatologic Surgical Procedures
01/2017
1Precision Medicine
04/2014
1Stem Cell Transplantation
09/2011
1Off-Label Use
02/2005
1Cryosurgery
07/2004